In addition, higher levels of proinflammatory Th9 and Th17 cell subsets were observed in comparison with acute forms of COVID-19, with a reduced capacity to express anti-inflammatory cytokines related to endothelial regeneration such as IL-22. The gene discussed is IL22; the disease is COVID-19.